CEMI Chembio Diagnostics upside potential

Chembio Diagnostics' analysts are forecasting revenues of US$54m in 2021, a substantial 56% improvement in sales compared to the last year.

CEMI follows its bigger more profitable brother CODX in price action.
Depending on the future development of the global pandemic, those stocks could grow rapidly.

On 12/3/2020 Craig Hallum brokerage Upgraded the stock from Hold to Buy from $5.00 to $10.00 price target.

Because of the offering, I've lowered my price target to 5.5usd.

I`m looking forward to read your opinion about CEMI.